A detailed history of Nvwm, LLC transactions in Amgen Inc stock. As of the latest transaction made, Nvwm, LLC holds 12 shares of AMGN stock, worth $3,403. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Previous 12 -0.0%
Holding current value
$3,403
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $2,890 - $3,512
11 Added 1100.0%
12 $3,000
Q1 2024

May 06, 2024

BUY
$268.87 - $324.56 $268 - $324
1 New
1 $0
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $4,064 - $4,953
18 Added 90.0%
38 $9,000
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $8,474 - $10,767
-37 Reduced 64.91%
20 $5,000
Q2 2022

Aug 04, 2022

BUY
$230.71 - $256.74 $1,384 - $1,540
6 Added 11.76%
57 $14,000
Q1 2022

May 11, 2022

BUY
$219.27 - $242.57 $3,946 - $4,366
18 Added 54.55%
51 $12,000
Q3 2021

Nov 03, 2021

SELL
$212.27 - $248.7 $2,759 - $3,233
-13 Reduced 28.26%
33 $7,000
Q2 2021

Aug 04, 2021

BUY
$233.58 - $259.14 $3,036 - $3,368
13 Added 39.39%
46 $11,000
Q4 2020

Feb 09, 2021

SELL
$216.38 - $257.67 $11,684 - $13,914
-54 Reduced 62.07%
33 $8,000
Q3 2020

Dec 10, 2020

BUY
$234.65 - $260.95 $938 - $1,043
4 Added 4.82%
87 $22,000
Q2 2019

Aug 07, 2019

SELL
$166.7 - $195.41 $420,417 - $492,824
-2,522 Reduced 96.81%
83 $15,000
Q1 2019

May 10, 2019

SELL
$180.87 - $203.88 $5,968 - $6,728
-33 Reduced 1.25%
2,605 $495,000
Q4 2018

Jan 29, 2019

BUY
$178.4 - $208.25 $451,887 - $527,497
2,533 Added 2412.38%
2,638 $514,000
Q2 2018

Aug 01, 2018

SELL
$166.05 - $186.51 $996 - $1,119
-6 Reduced 5.41%
105 $19,000
Q1 2018

May 17, 2018

SELL
$169.43 - $198.0 $986,760 - $1.15 Million
-5,824 Reduced 98.13%
111 $18,000
Q4 2017

Mar 15, 2018

BUY
$168.79 - $188.59 $1 Million - $1.12 Million
5,935
5,935 $1.03 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Nvwm, LLC Portfolio

Follow Nvwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nvwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nvwm, LLC with notifications on news.